Showing 1 - 9 results of 9 for search 'Anderson J Ryan', query time: 0.03s
Refine Results
-
1
-
2
Assessment of Acute Antivascular Effects of Vandetanib with High-Resolution Dynamic Contrast-Enhanced Computed Tomographic Imaging in a Human Colon Tumor Xenograft Model in the Nud... by Joo Ho Tai, Jean Tessier, Anderson J. Ryan, Lisa Hoffman, Xiaogang Chen, Ting-Yim Lee
Published 2010-09-01
Article -
3
Vascular Targeting in Pancreatic Cancer: The Novel Tubulin-Binding Agent ZD6126 Reveals Antitumor Activity in Primary and Metastatic Tumor Models by Axel Kleespies, Gudrun Köhl, Michael Friedrich, Anderson J. Ryan, Alan Barge, Karl-Walter Jauch, Christiane J. Bruns
Published 2005-10-01
Article -
4
-
5
The Effects of Vandetanib on Paclitaxel Tumor Distribution and Antitumor Activity in a Xenograft Model of Human Ovarian Carcinoma by Marta Cesca, Roberta Frapolli, Alexander Berndt, Valentina Scarlato, Petra Richter, Hartwig Kosmehl, Maurizio D'Incalci, Anderson J. Ryan, Raffaella Giavazzi
Published 2009-11-01
Article -
6
-
7
Single Dose of the Antivascular Agent, ZD6126 (N-Acetylcoichinol-O-Phosphate), Reduces Perfusion for at Least 96 Hours in the GH3 Prolactinoma Rat Tumor Model by Dominick J.O. McIntyre, Simon P. Robinson, Franklyn A. Howe, John R. Griffiths, Anderson J. Ryan, David C. Blakey, Ian S. Peers, John C. Waterton
Published 2004-03-01
Article -
8
Acute Tumor Response to ZD6126 Assessed by Intrinsic Susceptibility Magnetic Resonance Imaging by Simon P. Robinson, Tammy L. Kalber, Franklyn A. Howe, Dominick J.O. McIntyre, John R. Griffiths, David C. Blakey, Lynsey Whittaker, Anderson J. Ryan, John C. Waterton
Published 2005-05-01
Article -
9
Identification of anticancer drugs to radiosensitise <i>BRAF</i>-wild-type and mutant colorectal cancer by Rebecca Carter, Azadeh Cheraghchi-Bashi, Adam Westhorpe, Sheng Yu, Yasmin Shanneik, Elena Seraia, Djamila Ouaret, Yasuhiro Inoue, Catherine Koch, Jenny Wilding, Daniel Ebner, Anderson J. Ryan, Francesca M. Buffa, Ricky A. Sharma
Published 2019-06-01
Article